title: MPN blast phase: clinical challenge and assessing response.
authors.forename: Ruben A
authors.initials: RA
authors.lastname: Mesa
authors.forename: Raoul
authors.initials: R
authors.lastname: Tibes
mesh_terms: D001752:Blast Crisis / Q000473:pathology / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000473:pathology / Q000628:therapy; D009154:Mutation; D019653:Myeloablative Agonists / Q000627:therapeutic use; D009196:Myeloproliferative Disorders / Q000473:pathology / Q000628:therapy; D011087:Polycythemia Vera / Q000473:pathology / Q000628:therapy; D055728:Primary Myelofibrosis / Q000473:pathology / Q000628:therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D013920:Thrombocythemia, Essential / Q000473:pathology / Q000628:therapy; D019172:Transplantation Conditioning / Q000379:methods
chemical_list: D056572:Histone Deacetylase Inhibitors; D019653:Myeloablative Agonists; D047428:Protein Kinase Inhibitors; C507924:JAK2 protein, human; D053614:Janus Kinase 2